Printer Friendly Version  View printer-friendly version
<< Back
Array BioPharma To Present At The Cowen and Company Annual Healthcare Conference

BOULDER, Colo., Feb. 25, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Array BioPharma.



Cowen and Company Annual Healthcare Conference


Ron Squarer, Chief Executive Officer


Wednesday, March 4, 2015


9:20 a.m. Eastern Time


The Boston Marriott Copley Place, Boston, MA


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to



Tricia Haugeto

Array BioPharma Inc.



Logo -


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.

ShareThis Copy and Paste